Abbott Settled False Claims Over Infant Formula
The manufacturer agreed to pay $385 million after federal investigations into unsanitary production conditions.
Updated on Oct. 11, 2026 in Babies
Live Poll
Should food manufacturers be held strictly liable for contamination in their facilities, regardless of findings?
Abbott Laboratories has reached a $385 million settlement to resolve allegations that it submitted false claims related to infant formula produced at plants in Sturgis, Michigan, and Casa Grande, Arizona. The agreement addresses claims spanning from 2018 through 2022 during a time when the FDA investigated reports of bacterial contamination.
Why it matters
The settlement highlights oversight failures regarding food safety standards for infants and the subsequent impact on formula supply and health. Government investigators alleged that manufacturing practices prioritized production speed over rigorous safety testing.
Abbott will pay $348.7 million to the federal government and $36.3 million to state governments. This follows a period of heightened scrutiny where the company recalled products in 2022 following reports of infant hospitalizations and deaths.
The players
Abbott Laboratories
A major global healthcare and medical device company that produces a significant portion of the U.S. infant formula supply.
Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety and security of the nation's food supply.
The details
Regulators alleged that Abbott maintained unsanitary conditions by using temporary roof leak umbrellas to divert water in processing areas. The company reportedly increased production by running equipment past cleaning cycles while intentionally withholding bacterial test results from the FDA.
Timeline
January 1, 2018 to December 31, 2022 marked the period of alleged false claims.
February 17, 2022 was when Abbott issued a voluntary recall of powdered formulas.
June 2022 was when the Sturgis manufacturing plant resumed production.
October 2022 was when whistleblowers filed their initial lawsuit.
November 13, 2022 was when the U.S. government joined the litigation.
The Home Front
This settlement aligns with federal efforts to strengthen supply chain accountability for essential household goods. It reflects an ongoing trend of using financial litigation to penalize manufacturers for lapses in safety and quality control protocols.
Families who rely on specific formula brands should maintain awareness of company-issued recall notices by checking the official FDA safety database. If you have concerns about the specific formula your infant consumes, consult your pediatrician to verify that current products meet your safety needs.
The takeaway
This case underscores the importance of corporate transparency in manufacturing processes that directly impact infant health. Parents should regularly monitor the FDA recall portal and consult pediatric professionals for guidance on dietary choices for their children.
Further reading
Learn more about infant health and safety standards at Babies.
Source note: This article includes information reported by Lake and McHenry County Scanner.
Live Poll
Should food manufacturers be held strictly liable for contamination in their facilities, regardless of findings?
